News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CerRx, Inc. Secures World-Wide Exclusive License from John Wayne Cancer Institute and Children's Hospital Los Angeles on New Formulation of Vitamin A Analog to Treat Cancer


4/30/2009 10:11:14 AM

LOS ANGELES--(BUSINESS WIRE)--John Wayne Cancer Institute at Saint John’s Health Center, the National Institutes of Health (NIH) and Children’s Hospital Los Angeles (CHLA) have granted CerRx Inc., worldwide exclusive rights to intellectual property and know-how related to a novel formulation of a Vitamin A analog to treat cancer, as a single agent or in combination with partnering agents.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES